The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: An update on the regional and local epidemiology

Journal of Infection and Public Health

Volumn 5, Issue 3, 2012, Pages 233-243

  El Herte, Rima I ^a   Kanj, Souha S ^a   Matar, Ghassan M ^a   Araj, George F ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Carbapenemases; Detection; Lebanon; Multi drug resistant Enterobacteriaceae; NDM 1; Treatment

Indexed keywords

AVIBACTAM; AZTREONAM; BORONIC ACID DERIVATIVE; CARBAPENEM; CEFTAZIDIME; CLOXACILLIN; DIPICOLINIC ACID; DORIPENEM; ERTAPENEM; FOSFOMYCIN; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; DRUG SCREENING; ENTEROBACTERIACEAE; HUMAN; INFECTION CONTROL; LEBANON; MEDICAL PRACTICE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; LEBANON; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 84861347345     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2012.02.003     Document Type: Article

References (71)

1. Pfeifer Y., Cullik A., Witte W. Nosocomial infections. Int J Med Microbiol 2010, 300:371-379.
2. Samaha-Kfoury J.N., Araj G.F. Recent developments in β-lactamases and extended spectrum-β-lactamases. BMJ 2003, 327:1209-1213.
3. Pitout J.D. Infections with extended-spectrum β-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010, 70:313-333.
4. Walther-Rasmussen J., Høiby N. Class A carbapenemases. J Antimicrob Chemother 2007, 60:470-482.
5. Nordmann P. Gram-negative bacteriae with resistance to carbapenems. Med Sci (Paris) 2010, 26:950-959.
6. Matar G.M., Cuzon G., Araj G.F., Naas T., Corkill J., Kattar M.M., et al. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. Clin Microbiol Infect 2008, 14:887-888.
7. Matar G.M., Dandache I., Carraer A., Khairallah M.T., Nordamnn P., Sabra A., et al. Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum β-lactamase. Ann Trop Med Parasitol 2010, 104:271-274.
8. Poirel L., Al Maskari Z., Al Rashdi F., Bernabeu S., Nordmann P. NDM-1 producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother 2011, 66:304-306.
9. Jamal W, Rotimi VO, Albert MJ, Khodakhast FB, Udo EE, Al Sweih NA. Emergence of NDM-1 in a teaching hospital in Kuwait, ICAAC abstract number C1-1109, Chicago; 2011.
10. Kahan J.S., Kahan F.M., Goegelman R., Currie S.A., Jackson M., Stapley E.O., et al. Thienamycin, a new β-lactam antibiotic I. Discovery, taxonomy, isolation and physical properties. J Antibiot 1979, 32:1-12.
11. Girlich D., Poirel L., Nordmann P. CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2009, 53:832-834.
12. Bush K., Jacoby G.A. Updated functional classification of β-lactamases. Antimicrob Agents Chemother 2010, 54:969-976.
13. Queenan A.M., Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007, 20:440-458.
14. Poirel L., Pitou J.D., Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007, 501-512.
15. Aktas Z., Bal Kayacan Ç, Schneider I., Can B., Midilli K., Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul Turkey. Chemotherapy 2008, 54:101-106.
16. Guelmez D., Woodford N., Palepou M-FI, Mushtaq S., Metan G., Yakupogullari Y., et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008, 31:523-526.
17. Carrer A., Poirel L., Eraksoy H., Cagatay A.A., Badur S., Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul Turkey. Antimicrob Agents Chemother 2008, 52:2950-2954.
18. Carrer A., Poirel L., Yilmaz, Akan O.A., Feriha C., Cuzon G., et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010, 54:1369-1373.
19. Ikonomidis A., Labrou M., Afkou Z., Maniatis A.N., Sofianou D., Tsakris A., et al. First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-β-lactamase VIM-12. Antimicrob Agents Chemother 2007, 51:3038-3039.
20. Giakkoupi P., Pappa O., Polemis M., Vatopoulos A.C., Miriagou V., Zioga A., et al. Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. Antimicrob Agents Chemother 2009, 53:4048-4050.
21. Pournaras S., Poulou A., Voulgari E., Vrioni G., Kristo I., Tsakris A. Detection of the new metallo-β-lactamase VIM-19 along with KPC-2 CMY-2 and CTX-M-15 in Klebsiella pneumonia. J Antimicrob Chemother 2010, 65:1604-1607.
22. Pournaras S., Protonotariou E., Voulgari E., Kristo I., Dimitroulia E., Vitti D., et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009, 64:348-352.
23. Tsakris A., Kristo I., Poulou A., Markou F., Ikonomidis A., Pournaras S. First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests. J. Antimicrob. Chemother. 2008, 62:1257-1260.
24. Giakkoupi P., Xanthaki A., Kanelopoulou M., Vlahaki A., Miriagou V., Kontou S., et al. VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 2003, 41:3893-3896.
25. Yong D., Toleman M.A., Giske C.G., Cho H.S., Sundman K., Lee K., et al. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009, 53:5046-5054.
26. Multi-resistant hospital bacteria linked to India and Pakistan. Health protection report, vol. 3(26); 2009.
27. Poirel L., Fortineau N., Nordmann P. International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother 2011, 55:1821-1822.
28. El-Herte RI, Araj GF, Matar GM, Baroud M, Kanafani ZA, Kanj SK. Detection of carbapenem-resistant E. coli and k. pneumoniae producing NDM-1 in Lebanon. J Infect Dev Ctries 2012;(April issue, in press).
29. Kumarasamy K.K., Toleman M.A., Walsh T.R., Bagaria J., Butt F.A., Balakrishnan R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
30. Walther-Rasmussen J., Høiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006, 57:373-383.
31. Kohlenberg A., Bruemmer S., Higgins P.G., Sohr D., Piening B.C., de Grahl C., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 2009, 58:1499-1507.
32. Jacoby G.A. AmpC β-lactamases. Clin Microbiol Rev 2009, 22:161-182.
33. Baroud M, Araj GF, Wakim R, Kanj SS, Kanafani ZA, Khairallah M, Sabra A, Shehab M, Dbaibo G, Matar GM. Underlying mechanism of carbapenem resistance in ESBL producing Enterobacteriaceae at a tertiary care center in Lebanon, ICAAC abstract number C1-1108, Chicago; 2011.
34. Poirel L., Heritier C., Toluen V., Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumonia. Antimicrob Agents Chemother 2004, 48:15-22.
35. Gacar G.G., Midilli K., Kolayli F., Ergen K., Gundes S., Hosoglu S., et al. Genetic and enzymatic properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 2005, 49:4400-4403.
36. Livermore D.M. Has the era of untreatable infections arrived?. J Antimicrob Chemother 2009, 64(Suppl. 1):i29-i36.
37. Hawser S.P., Bouchillon S.K., Hoban D.J., Hackel M., Johnson J.L., Badal R.E. Klebsiella pneumoniae isolates possessing KPC β-lactamase in Israel, Puerto Rico Colombia and Greece. Int J Antimicrob Agents 2009, 34:380-393.
38. Psichogiou M., Tassios P.T., Avlamis A., Stefanou I., Kosmidis C., Platsouka E., et al. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens Greece: a prospective survey. J Antimicrob Chemother 2008, 61:59-63.
39. Tokatlidou D., Tsivitanidou M., Pournaras S., Ikonomidis A., Tsakris A., Sofianou D. Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a University Hospital. J Clin Microbiol 2008, 46:1005-1008.
40. Giakkoupi P., Maltezou H., Polemis M., Pappa O., Saroglou G., Vatopoulos A. The Greek system for the surveillance of antimicrobial resistance KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 2009, 14(21).
41. Kontopoulou K., Protonotariou E., Vasilakos K., Kriti M., Koteli A., Antoniadou E., et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2β-lactamase resistant to colistin. J Hosp Infect 2010, 76:70-73.
42. Zioga A., Miriagou V., Tzelepi E., Douzinas E., Tsakiri M., Legakis N.J., et al. The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2. Int J Antimicrob Agents 2010, 36:190-191.
43. Marchaim D., Navon-Venezia S., Schwaber M.J., Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization epidemiology, and outcomes. Antimicrob Agents Chemother 2008, 52:1413-1418.
44. Navon-Venezia S., Chmelnitsky I., Leavitt A., Schwaber M.J., Schwartz D., Carmeli Y. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006, 50:3098-3101.
45. Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M.J., Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli Hospital. Antimicrob Agents Chemother 2007, 51:3026-3029.
46. Leavitt A., Carmeli Y., Chmelnitsky I., Goren M.G., Ofek I., Navon-Venezia S. Molecular epidemiology sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother 2010, 4:3002-3006.
47. Lopez J.A., Correa A., Navon-Venezia S., Correa A.L., Torres A., Briceno D.F., et al. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect 2011, 17:52-56.
48. Cuzon G, Naas T, Carrer A, Honderlick P, Cerf C, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing β-lactamase OXA-48 in Klebsiella pneumoniae from Egypt. Abstract number C2-649 at the 49th ICAAC.
49. Guerin F., Henegar C., Spiridon G., Launay O., Salmon-Ceron D., Poyart C. Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-β-lactamase gene from Saudi Arabia. J Antimicrob Chemother 2005, 56:601-602.
50. McGettigan S.E., Andreacchio K., Edelstein P.H. Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases. J Clin Microbiol 2009, 47:785-786.
51. Miriagou V., Cornaglia G., Edelstein M., Galani I., Giske C.G., Gniadkowski M., et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010, 16:112-122.
52. Nordmann P., Cuzon G., Naas T. The real threat of Klebsiella pneumoniae carbapenemase producing bacteria. Lancet Infect Dis 2009, 9:228-236.
53. Overturf G. Carbapenemases: a brief review for pediatric infectious disease specialists. Pediatr Infect Dis J 2010, 29:68-70.
54. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 21st informational supplement, M100-S21.
55. Stuart J.C., Leverstein-Van Hall M.A., on behalf of members of the Dutch Working Party on the Detection of Highly Resistant Microorganisms Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010, 36:205-210.
56. Giske C.G., Gezelius L., Samuelsen Ø., Warner M., Sundsfjord A., Woodford N. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae using meropenem discs supplied with boronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011, 17:552-556.
57. Pournaras S., Poulou A., Tsakris A. Inhibitor-based methods for the detection of KPC carbapenemase producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 2010, 65:1319-1321.
58. Hirsch E.B., Tam V.H. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010, 65:1119-1125.
59. Cuzon G., Naas T., Nordmann P. Carbapénèmases de type KPC: quel enjeu en microbiologie clinique?. Pathologie Biologie 2010, 58:39-45.
60. Schechner V., Straus-Robinson K., Schwartz D., Pfeffer I., Tarabeia j., Moskovich R., et al. Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol 2009, 47:3261-3265.
61. Bratu S., Tolaney P., Karumudi U., Quale J., Mooty M., Nichani S., et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005, 56:128-132.
62. Kanj S.S., Kanafani Z.A. Current concepts in antimicrobial therapy against resistant Gram-negative organisms: extended-spectrum β-lactamase-producing Enterobacteriaeceae carbapenem-resistant Enterobaceriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 2011, 86:250-259.
63. Castanheira M., Sader H.S., Deshpande L.M., Fritsche T.R., Jones R.N. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing Enterobacteriaceae: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 2008, 52:570-573.
64. Anthony K.B., Fishman N.O., Linkin D.R., Gasink LB, Edelstein P.H., Lautenbach E. Clinical and microbiological outcomes of serious infections with multidrug-resistant Gram-negative organisms treated with tigecycline. Clin Infect Dis 2008, 46:567-570.
65. Samra Z., Ofira O., Lishtzinsky Y., Madar-Shapiro L., Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007, 30:525-529.
66. Endimiani A., Patel G., Hujer K.M., Swaminathan M., Perez F., Rice L.B., et al. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 2010, 54:526-529.
67. Livermore D.M., Mushtaq S., Warner M. Activity of BAL30376 (monobactam BAL197641BAL298801clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms. J Antimicrob Chemother 2010, 65:2382-2395.
68. Livermore D.M., Mushtaq S., Warner M., Zhang G., Maharjan S., Doumith M., et al. Activity of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2011, 55:390-394.
69. Paukner S., Hesse L., Prezelj A., Solmajer T., Urleb U. In vitro activity of LK-157, a novel tricyclic carbapenem as broad-spectrum β-lactamase inhibitor. Antimicrob Agents Chemother 2009, 53:505-511.
70. Petersen P.J., Hal Jones C., Venkatesan A.M., Mansour T.S., Projan S.J., Bradford P.A. Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem β-lactamase inhibitor BLI-489. Antimicrob Agents Chemother 2009, 53:370-384.
71. Endimiani A., Hujer K.M., Hujer A.M., Armstrong E.S., Choudhary Y., Aggen J.B., et al. ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrob Agents Chemother 2009, 53:4504-4507.